Clinical Trials Directory

A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Trial of Amoxicillin Compared With Placebo for Pneumonia in Children Aged 2-59 Months

AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma

Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates

PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss

International NaProTechnology Evaluation and Surveillance of Treatment for Infertility and Miscarriage (iNEST)

Multiple Intervention and AUdit in Renal Diseases to Optimize Care

Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)

Strategies to Help Adult ED Patients Quit Smoking

Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar Disorder

Assessing the Rates of Major Complications in Combined Mini-incision Microscopic Varicocelectomy

Dual Diagnosis (Psychosis and Cannabismisuse): Comparison of Specialized Treatment Versus Unspecified Treatment

Intra-articular Glucocorticoid Treatment of the Elbow

GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere

The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control

Use Of SB-705498 In The Acute Treatment Of Migraine

Tobacco Cessation Via Public Health Dental Clinics

Learning Effective Approaches to Prevention

Investigation of Changes in Bone Scan Imaging Before and After Intravenous Bisphosphonate Therapy for Osseous Metastases From Breast Cancer

Prophylactic Antibiotic in Treatment of Fingertip Amputation

Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

Influence of N-Acetylcysteine on Morbidity, Oxygenation and Cytokine Levels in Partial or Total Esophagectomy for Cancer

Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute

Posterior Capsule Opacification (PCO) With Single Piece Hydrophobic Versus Hydrophillic Intraocular Lens (IOL)

Interactive Voice Response (IVR) for Methadone Patients

Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast Cancer

Prospective Randomized Trial of Navigated and Conventional TKA

Nodal Status in Adenocarcinoma of the Esophagus an Cardia

The Early History of Universal Screening for Metabolic Disorders

Efficacy and Safety of Electrical Versus Pharmacological Cardioversion in Early Atrial Fibrillation

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)

HALT Progression of Polycystic Kidney Disease Study B

A Simple Clinical Tool to Help Assess Patient Volume (Fluid) Status

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin

Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed Conditions

Wound Infiltration and Breast Cancer Surgery

An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy

Comprehensive Magnetic Resonance of Peripheral Arterial Disease

Prospective Evaluation of FibroScan in Patients Treated With Methotrexate

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition

Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy

Epidemiology and Long-term Outcome of Patients With VHD

Midvastus Versus Medial Parapatellar Approach for Minimally Invasive Total Knee Arthroplasty

Open-Label,Singel Center Study of Alefacept in Patients With Atopic Dermatitis

Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn

Physical Activity After Stroke: How Does it Effect Chronical Inflammation and Insulin Sensitivity

A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies